Skip Navigation



NDT Advance Access published online on June 25, 2009

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfp302
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/11/3288    most recent
gfp302v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lennon, R.
Right arrow Articles by Welsh, G. I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lennon, R.
Right arrow Articles by Welsh, G. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy

Rachel Lennon1, Deborah Pons1, Matthew A. Sabin2, Christina Wei2, Julian P. Shield2, Richard J. Coward1, Jeremy M. Tavaré3, Peter W. Mathieson1, Moin A. Saleem1 and Gavin I. Welsh1

1 Academic and Children's, Renal Unit, Paul O’Gorman Lifeline Centre, University of Bristol, Southmead Hospital, Bristol BS10 5NB 2 Department of Paediatric Endocrinology 3 Department of Biochemistry, University of Bristol, UK

Correspondence and offprint requests to: Gavin Welsh; E-mail: G.I.Welsh{at}bristol.ac.uk



  Abstract

Background. Cellular insulin resistance is the hallmark of type 2 diabetes and predominantly affects adipose and muscle cells. The saturated free fatty acid palmitate is elevated in insulin-resistant states and may directly contribute to cellular insulin resistance. A spectrum of renal disease is associated with increased markers of insulin resistance, although direct causal mechanisms are not known. In the kidney, glomerular podocytes are novel insulin-sensitive cells that have the ability to rapidly transport glucose. In this study, we tested the hypothesis that palmitate would induce insulin resistance in podocytes.

Methods. Conditionally immortalized human podocytes were cultured for up to 24 h with 375–750 µM palmitate. Functional effects on glucose uptake and ceramide production were measured. Gene expression was investigated using a focused gene array, and protein signalling and trafficking were studied with Western blotting and immunofluorescence.

Results. We found that palmitate blocked insulin-stimulated glucose uptake in human podocytes. This was associated with increased ceramide production, and use of the ceramide inhibitors myriocin and fumonisin B1 partially recovered the insulin sensitivity. At the level of transcription, palmitate downregulated genes associated with several pathways involved in insulin signalling. At the protein level, phosphorylation of the insulin receptor, IRS1 and PKB was reduced and there was impaired translocation of GLUT4 to the cell surface.

Conclusion. This is the first study to demonstrate a direct effect of saturated fatty acids on podocyte function. These findings may represent a novel link between systemic insulin resistance and the development of nephropathy.

Keywords: diabetic nephropathy; glucose uptake; insulin resistance; palmitate; podocyte

Received for publication: 31.12.08
Accepted in revised form: 27. 5.09


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.